Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04637035 · ClinicalTrials.gov registry record · NA

Supportive Oncology Care at Home Post-Discharge

A NA study of Cancer, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT04637035: Active NA study of Cancer, sponsored by Massachusetts General Hospital.

NCT04637035 is a NA study of Cancer that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 110 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04637035, a NA study of Cancer, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

This study is evaluating if a program that involves remote monitoring and home-based care may improve the post-discharge care of recently hospitalized patients with advanced cancer. The Supportive Oncology Care at Home intervention consists of three key components: 1. Remote patient monitoring (e.g. patient-reported symptoms, home-monitored vital signs and body weight); 2. A Medically Home care model for symptom assessment, evaluation, and management (e.g. triggers for phone calls and visits to patients' homes to address and manage any concerning issues identified); 3. Structured communication with the oncology team to ensure continuity of care.

Conditions Studied

Cancer

Interventions

  • OTHER Supportive Oncology Care at Home

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital Cancer Center - Boston

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2021-08-19
Est. Completion 2025-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04637035

The ClinicalTrials.gov registry entry for NCT04637035 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Supportive Oncology Care at Home is the first listed.

NCT04637035 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04637035 about?

NCT04637035 is a clinical study titled "Supportive Oncology Care at Home Post-Discharge". This study is evaluating if a program that involves remote monitoring and home-based care may improve the post-discharge care of recently hospitalized patients with advanced cancer. The Supportive Oncology Care at Home intervention consists of three key components: 1. Remote patient monitoring (e....

What is the current status of trial NCT04637035?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2021-08-19. Estimated completion is 2025-12-31.

What conditions does trial NCT04637035 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT04637035?

The interventions under investigation include: Supportive Oncology Care at Home (OTHER).

Who is sponsoring clinical trial NCT04637035?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04637035 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.